UnitedHealth (UNH) stock slips as House sets CEO hearing and Senate deadline looms
UnitedHealth shares fell 0.7% to $344.30 after House leaders set a Jan. 22 hearing with major insurer CEOs on affordability. Senate Democrats revived a probe into Optum’s nursing-home programs, giving UnitedHealth until Jan. 28 to respond. Investors await UnitedHealth’s 2026 guidance and full-year results on Jan. 27. CVS Health, Cigna, and Elevance shares also declined.